Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2017

View Archived Issues

Pan-CK2 inhibitor BMS-159 chosen for development as anticancer candidate

IdeS reduces donor-specific antibodies allowing for HLA-incompatible transplantation

Genentech presents data from phase I trial of influenza B candidate MHAB-5553A

BMP inhibition a novel pharmacological strategy for multiple hereditary exostoses

Trisubstituted benzene CGRP antagonists for migraine created at Merck & Co.

PharmAkea completes phase I study of PAT-1251

New phase IIa trial tests S. hominis lotion for atopic dermatitis

Sun Pharma Advanced Research discovers novel Bruton tyrosine kinase inhibitors

Pharmakea presents new lysyl oxidase homolog 2 inhibitors

Takeda submits Japanese NDA for vedolizumab for ulcerative colitis

FDA grants orphan drug designation to Jotrol for Friedreich's ataxia

CIRM grant supports Cellerant's development of CLT030-ADC for AML

Phase Ib results reported for proinsulin peptide immunotherapy in subjects with type 1 diabetes

AC Immune expands neurodegenerative pipeline with new antibodies against alpha-synuclein and TDP-43

Topas signs research and option agreement with Lilly focused on antigen-specific tolerance induction

Janssen describes synthesis of GPR40 full agonists for type 2 diabetes

CRISPR Therapeutics and Massachusetts General Hospital collaborate to develop T-cell therapies

Obesity compounds begin phase I trials under Zealand and Boehringer Ingelheim collaboration

Phase III study of Ace-ER in GNE myopathy misses primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...